Silvia Jenni
Schlieren, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.
Journal: Journal for immunotherapy of cancer
Published: March 27, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.
Journal: Cancer research communications
Published: March 18, 2026
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.
Journal: Blood
Published: February 20, 2025
Repurposing anthelmintic agents to eradicate resistant leukemia.
Journal: Blood cancer journal
Published: May 05, 2020
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.
Journal: The Journal of clinical investigation
Published: December 20, 2019
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2019
TNFR2 is required for RIP1-dependent cell death in human leukemia.
Journal: Blood advances
Published: August 05, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling.
Journal: Cell death & disease
Published: March 26, 2019
Single-cell analysis of structural variations and complex rearrangements with tri-channel processing.
Journal: Nature biotechnology
Published: February 27, 2019
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.
Journal: Haematologica
Published: August 05, 2018
Last Updated: 09/26/2026